Recurrent miscarriage and inherited thrombophilia: Diagnostic work-out and therapeutic management;Trombofilia congénita y aborto recurrente: Estrategias diagnósticas y recomendaciones terapéuticas

Medicina Clinica

Volumn 125, Issue 16, 2005, Pages 626-631

  Alijotas Reig, Jaume ^a   Ferrer Raventós, Juan Carlos ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Instituto de Obstetricia y Ginecología   (Spain)

Author keywords

Diagnostic; Inherited trombophilia; Management; Recurrent miscarriages

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; FIBRINOGEN; OXIDOREDUCTASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; CONCEPTION; HUMAN; INFERTILITY; PREGNANCY; PREGNANT WOMAN; PROTEIN POLYMORPHISM; REVIEW; RISK FACTOR; RISK REDUCTION; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA;

EID: 28944438424     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080830     Document Type: Article

References (67)

1. Aguilera C, Vallano A. Uso de heparinas de bajo peso molecular en el embarazo. Med Clin (Barc). 2002;18:634-5.
2. Greer IA. The challenge of thrombophilia in maternal-fetal medicine. N Engl J Med. 2000;342:424-5.
3. Lockwood CJ. Inherited thrombophilias in pregnant patierits: detection and treatment paradigm. Obstet Ginecol. 2002;99:333-41.
4. Buchholz T, Thaler CJ. Inherited thrombophilia: impact on human reproduction. Am J Reprod Immunol. 2003;50:20-32.
5. Mousa HA, Alfirevic Z. Thrombophilia and adverse pregnancy outcome. Croat Med J. 2001;42:135-45.
6. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol. 2000;96:45-9.
7. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Human Reprod 2000;15:1830-3.
8. Brenner B. Thrombophilia and fetal loss. Semin Thromb Haemost. 2003;29:165-70.
9. Gris JC, Ripart-Neveu S, Maugard O, Tailland ML, Brun S, Courticu C, et al. The Nimes Obstetricians Haematologists (NOHA) Study. Thromb Haemost. 1997;77:1096-103.
10. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Haemost. 2003;29:171-4.
11. Stone S, Khamastha MA, Poston L. Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus. 2002;10:67-74.
12. Von Landerberg P, Matthias P, Zaech J, Schultz M, Lorber M, Blank M. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol. 2003;49:51-6.
13. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983;287:1088-9.
14. Cervera R, Piette JC, Font J, Khamastha MA, Shoenfeld Y, Camps M, et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002;46:1019-27
15. Coulam C. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol. 1991;26:23-7.
16. Preston FE, Rosendaal RF, Walker ID, Briet E, Bemtorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913-6.
17. Roque H, Paidas M, Rebarber A, Khan S, Kuzy A, Lockwood CJ. There is no association between thrombophilia and recurrent first-trimester loss. Obstet Gynecol. 2001;184:S15.
18. Dizon-Townson DS, Kinney S, Branch DW, Wrad K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. Am J Reprod Immunol. 1997;34:217-23.
19. Meinardi JR, Middeldorp S, De Kam PJ, Koopman MM, Van Pampus EC, Hamulyak K, et al. Increased risk for foetal loss in carriers of the factor V Leiden mutation. Ann Intern Med. 1999;130:736-9.
20. Gopel W, Ludwig M, Junge AK, Kochlmann T, Diedrich K, Moller J. Selection pressure for the factor-V-Leiden mutation and embryo implantation. Lancet. 2001;358:1238-9.
21. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis. Thromb Haemost. 2004;91:700-11.
22. Castoldi E, Simioni P, Kalafatis M, Lunghi B, Tormene D, Girelli D, et al. Combinations of 4 mutations affecting the prothrombinase complex in a thrombophilic family. Blood. 2000;96:1443-8.
23. Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin increases the risk in the first trimester. Am J Reprod Immunol. 2001;46:124-31.
24. Kutten WH, Park VM, Dietcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1999;71:1048-53.
25. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphism are common in women with fetal loss without apparent cause. Thromb Haemost. 1999;82:6-9.
26. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med. 2000;343:1015-8.
27. Finazzi G, Barbui T. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S. Thromb Haemost. 1994;71:15-8.
28. López-Quesada EL, Vilaseca MA, González S. Homocisteína y gestación. Med Clin (Barc). 2000;115:352-6.
29. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequeney of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
30. Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage. Fertil Steril. 1999;72:765-74.
31. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiophatic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002;77:342-7.
32. Adamek L, Jankowski M, Sanak M, Krzanowski M, Grzanka P, Nizankowska E, et al. Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism. Pol Arch Med Wewn. 1999;102:1095-9.
33. Erkan D, Bateman H, Lockshin MD. Lupus anticoagulant-hipoprothrombinemia syndrome associated with systemic lupus erythematosus: report of two cases and review of literature. Lupus. 1999;8:560-4.
34. Erkan D, Yazici Y, Lockshin MD. Lupus anticoagulant-hypoprotrombinemia syndrome and pregnancy. Lupus. 2001;10:311-2.
35. Stormorken H, Gjemdal T, Bjoro K. Lupus anticoagulant: a unique case with lupus anticoagulant and habitual abortion together with antifactor II antibody and bleeding tendency. Gynecol Obstet Invest. 1988;26:83-8.
36. Ordi J, Vilardell M, Oristrell J, Valdés M, Knobel A, Alijotas J, et al. Bleeding in patients with lupus anticoagulant. Lancet. 1984;2:868-9.
37. Alijotas-Reig J, Farrer-Raventós JC. Life-threatening bleeding, pregnancy and lupus anticoagulant: success after steroid and anticoagulant therapy. Am J Reprod Immunol. 2004;52:129-32.
38. Goodwin TM. Congenital hypofibrinogenemia in pregnancy. Obstet Gynecol Surv. 1989;44:157-61.
39. Braulke I, Pruggmayer M, Melloh P, Hinney B, Kostering H, Gunther E. Factor XII deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil Steril. 1993;59:98-101.
40. Yamada H, Kato EH, Ebina Y, Kishida T, Hoshi N, Kobashi G, et al. Factor XII deficiency in women with recurrent miscarriage. Gynecol Obstet. Invest. 2000;49:80-3.
41. Matsura T, Kobayashi T, Asashina T, Kanayama N, Terao T. Is factor XII deficiency related to recurent miscarriage? Semin Thromb Haemost. 2001;27:115-20.
42. Catto AJ, Kolher HP, Coore J, Mansfield MW, Stickland MH, Grant PJ. Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood. 1999;93:906-8.
43. Anwar R, Gallivan L, Edmonds SD, Markham AF. Genotype/fenotype correlations for coagulation factor XIII. Specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood. 1999;93:897-905.
44. Lane DA, Grant PJ. Role of haemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000;95:1517-32.
45. Coumans AB, Huijgens PC, Takobs C, Schats R, De Vrics SI, Van Pampus MG, et al. Haentostatie and metabolic abnormalities in women with unexplained recurrent abortion. Human Reprod. 1999;14:211-4.
46. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res. 1999;94:271-305.
47. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, et al. The 4G/4G polymorphism in the hypofibrinolytic plasminogen activador inhibidor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism. 2000;20:1387-91.
48. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, et al. The 4G/4G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclapmsia. J Hum Genet. 2000;45:138-41.
49. Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med. 1993;122:606-15.
50. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, et al. Angiotensin-converting enzyme DD genotype, angiotensin type I receptor CC genotype, and hyperhomocysteinemia increase first-trimestre fetal-loss susceptibility. Blood Coagul Fibrinolysis. 2000;11:657-62.
51. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348:913-6.
52. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Tagaki A, Suzuki M, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 2000;106:873-8.
53. Khong TY, Hague WM. The placenta in maternal hyperhomocysteinemia. Br J Obstet Gynecol. 1999;106:273-8.
54. Lockwood CJ. Inherited thrombophilia in pregnant patients. Prenat Neonat Med. 2001;6:3-14.
55. Kupferminc MJ, Eldor A. Inherited thrombophilia and gestacional vascular complications. Semin Thromb Haemost. 2003;29:185-93.
56. Brenner B, Vulfsosns SL, Lanir N, Nahir M. Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis. Br J Haematol. 1996;94:166-7.
57. Wilson AW, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JCH, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309-11.
58. Alijotas-Reig J, Izquierdo M, Cusido MT, Carrera-Macia JM, Ribera M. Antinuclear antibodies, complement level, hypergammaglobulinemia and spontaneous intrauterine hematoma in pregnant women. Am J Reprod Immunol. 2003;49:1-6.
59. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584-9.
60. Kutteh WH, Ermel LD. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol. 1996;35:402-7.
61. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Human Reprod. 1997;12:1171-5
62. Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with antiphospholipid antibodies. BMJ. 1997;314:253-7.
63. Bick RL. Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex recurrent miscarriage syndrome cooperative group. Clin Appl Thromb Hemost. 2000;6:115-25.
64. Jilma B, Kamath S, Lip YL. Antithrombotic therapy in special circunstances. I-pregnancy and cancer. BMJ. 2003;326:3740-3.
65. Ginsberg JS, Greer IA, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119 Suppl:1229-31.
66. Wetz RG. Anaestheological aspects of pregnancy in patients with rheumatic diseases. Lupus. 2004;13:699-703.
67. Bick RL, Hoppensteadt D. Recurrent miscarriages syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb Hemost. 2005;11:1-13.